Our Portfolio

34 companies across digital health, biotech, and medical devices. We invest at the earliest signal of category-defining potential.

NovaTract

Digital Health

Remote cardiac monitoring for post-surgical patients. Real-time data from discharge through recovery.

Series B Founded 2019

GenBridge Therapeutics

Biotech

Gene therapy platform targeting rare inherited metabolic disorders with a focus on pediatric populations.

Series A Founded 2020

ClearPath Diagnostics

Diagnostics

AI-powered pathology reading for early cancer detection. Reducing time-to-diagnosis in community hospital settings.

Series B Founded 2018

OrthoSync

Medtech

Smart orthopedic implants with real-time load monitoring. Enabling evidence-based post-surgical rehab protocols.

Series A Founded 2021

PulseAI

Digital Health

Predictive sepsis detection for ICU environments. Clinically validated model with 6-hour early-warning lead time.

Series A Founded 2020

AxonBio

Biotech

CRISPR-based neurodegenerative disease treatments. Lead program targeting Huntington's disease in Phase I trials.

Series A Founded 2021

LumenDerm

Medtech

Wearable photobiomodulation device for chronic wound healing. FDA-cleared for diabetic ulcer management.

Series A Founded 2022

CareCircle

Digital Health

Care coordination platform for complex chronic disease patients. Acquired and integrated into a national health system.

Acquired Founded 2017

VeriPath

Diagnostics

Liquid biopsy platform for early-stage colorectal cancer screening. 87% sensitivity in prospective clinical study.

Series B Founded 2019

NeuralSync

Digital Health

Closed-loop neurostimulation for treatment-resistant depression. Breakthrough Device designation received in 2025.

Series A Founded 2022

Helix Pharma

Biotech

mRNA vaccine platform for infectious disease prevention. NYSE-listed following successful Phase III data readout.

IPO Founded 2018

SensorX Medical

Medtech

Minimally invasive biosensor capsule for GI tract monitoring. First-in-class device with novel wireless telemetry.

Series A Founded 2023

Not on this list yet?

We're always looking for the next generation of healthcare founders.

Pitch to Us